Trials / Not Yet Recruiting
Not Yet RecruitingNCT07468656
SCLC Tarlatamab Blood Collection
Analysis of Blood Samples in Small Cell Lung Cancer Patients Treated With Tarlatamab
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (estimated)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The overall objective of this project is to prospectively collect blood samples throughout treatment with tarlatamab in patients with small cell lung cancer (SCLC). These samples will then be analyzed through a variety of assays to better characterize tarlatamab in the real-world setting. The investigators will prospectively collect blood samples from 25 patients on days 1, 8, and 15 of tarlatamab treatment, as well as after each interval scan for disease monitoring. The investigators will also collect patient data including demographics and baseline characteristics, primary diagnosis, treatment history, and disease monitoring and progression.
Conditions
Timeline
- Start date
- 2026-05-01
- Primary completion
- 2028-12-01
- Completion
- 2028-12-01
- First posted
- 2026-03-12
- Last updated
- 2026-03-12
Source: ClinicalTrials.gov record NCT07468656. Inclusion in this directory is not an endorsement.